Metabolism and pharmacokinetic studies of misoprostol
Absorption, metabolism and excretion of radiolabelled misoprostol were studied in laboratory animals and in humans. Dog and man were similar in terms of key parameters examined. Misoprostol itself was not present in plasma after its oral administration to humans. Misoprostol was rapidly converted by...
Gespeichert in:
| Veröffentlicht in: | Digestive diseases and sciences 1985-11, Vol.30 (11 Suppl), p.126S-128S |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 128S |
|---|---|
| container_issue | 11 Suppl |
| container_start_page | 126S |
| container_title | Digestive diseases and sciences |
| container_volume | 30 |
| creator | Schoenhard, G Oppermann, J Kohn, F E |
| description | Absorption, metabolism and excretion of radiolabelled misoprostol were studied in laboratory animals and in humans. Dog and man were similar in terms of key parameters examined. Misoprostol itself was not present in plasma after its oral administration to humans. Misoprostol was rapidly converted by de-esterification to its free acid. This metabolite possesses significant desired pharmacological activity. Further metabolic conversion occurs over time via beta-oxidation of the alpha side chain, omega-oxidation of the beta side chain and reduction to the prostaglandin F analogs. The serum protein binding of the free acid metabolite of misoprostol was similar in young (81-88%) and elderly (81-89%) people. Binding was concentration-independent and was not altered by drugs which one would expect to be co-administered with misoprostol. In the rat, misoprostol neither inhibited nor induced drug metabolizing enzymes. A radio-immunological assay for measurement of the free acid metabolite in human plasma has been developed. This method has a sensitivity of 23 pg/ml and appears to be sufficiently sensitive for use in clinical trials. |
| doi_str_mv | 10.1007/bf01309397 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76425224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76425224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-5c748757a87192e6bff67cb7e8a59687c6baa0a09c6c97e438b45008921d9c9e3</originalsourceid><addsrcrecordid>eNo9kDFPwzAQhS0EKqWwsCNlYkAKnO3YZ49QUUAqYoE5sp2LCCR1iZOBf09QC9Pd8Om9p4-xcw7XHABvfA1cgpUWD9icK5S5UNocsjlwPf2c62N2ktIHAFjkesZm0koBhZwz9UyD87FtUpe5TZVt313fuRA_mw0NTcjSMFYNpSzWWdekuO1jGmJ7yo5q1yY6298Fe1vdvy4f8_XLw9Pydp0HiTjkKmBhUKEzyK0g7etaY_BIximrDQbtnQMHNuhgkQppfKEAjBW8ssGSXLDLXe7U-zVSGsppRKC2dRuKYypRF0IJUUzg1Q4M08DUU11u-6Zz_XfJofx1VN6t_hxN8MU-dfQdVf_oXor8AbTkYH0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76425224</pqid></control><display><type>article</type><title>Metabolism and pharmacokinetic studies of misoprostol</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Schoenhard, G ; Oppermann, J ; Kohn, F E</creator><creatorcontrib>Schoenhard, G ; Oppermann, J ; Kohn, F E</creatorcontrib><description>Absorption, metabolism and excretion of radiolabelled misoprostol were studied in laboratory animals and in humans. Dog and man were similar in terms of key parameters examined. Misoprostol itself was not present in plasma after its oral administration to humans. Misoprostol was rapidly converted by de-esterification to its free acid. This metabolite possesses significant desired pharmacological activity. Further metabolic conversion occurs over time via beta-oxidation of the alpha side chain, omega-oxidation of the beta side chain and reduction to the prostaglandin F analogs. The serum protein binding of the free acid metabolite of misoprostol was similar in young (81-88%) and elderly (81-89%) people. Binding was concentration-independent and was not altered by drugs which one would expect to be co-administered with misoprostol. In the rat, misoprostol neither inhibited nor induced drug metabolizing enzymes. A radio-immunological assay for measurement of the free acid metabolite in human plasma has been developed. This method has a sensitivity of 23 pg/ml and appears to be sufficiently sensitive for use in clinical trials.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/bf01309397</identifier><identifier>PMID: 3932043</identifier><language>eng</language><publisher>United States</publisher><subject>Alprostadil - analogs & derivatives ; Alprostadil - metabolism ; Alprostadil - pharmacology ; Animals ; Biotransformation ; Blood Proteins - metabolism ; Cimetidine - pharmacology ; Dogs ; Erythrocytes - metabolism ; Female ; Half-Life ; Haplorhini ; Humans ; Intestinal Absorption ; Kinetics ; Liver - drug effects ; Liver - enzymology ; Male ; Mice ; Misoprostol ; Mixed Function Oxygenases - metabolism ; Protein Binding ; Ranitidine - pharmacology ; Rats ; Tissue Distribution</subject><ispartof>Digestive diseases and sciences, 1985-11, Vol.30 (11 Suppl), p.126S-128S</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-5c748757a87192e6bff67cb7e8a59687c6baa0a09c6c97e438b45008921d9c9e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3932043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schoenhard, G</creatorcontrib><creatorcontrib>Oppermann, J</creatorcontrib><creatorcontrib>Kohn, F E</creatorcontrib><title>Metabolism and pharmacokinetic studies of misoprostol</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>Absorption, metabolism and excretion of radiolabelled misoprostol were studied in laboratory animals and in humans. Dog and man were similar in terms of key parameters examined. Misoprostol itself was not present in plasma after its oral administration to humans. Misoprostol was rapidly converted by de-esterification to its free acid. This metabolite possesses significant desired pharmacological activity. Further metabolic conversion occurs over time via beta-oxidation of the alpha side chain, omega-oxidation of the beta side chain and reduction to the prostaglandin F analogs. The serum protein binding of the free acid metabolite of misoprostol was similar in young (81-88%) and elderly (81-89%) people. Binding was concentration-independent and was not altered by drugs which one would expect to be co-administered with misoprostol. In the rat, misoprostol neither inhibited nor induced drug metabolizing enzymes. A radio-immunological assay for measurement of the free acid metabolite in human plasma has been developed. This method has a sensitivity of 23 pg/ml and appears to be sufficiently sensitive for use in clinical trials.</description><subject>Alprostadil - analogs & derivatives</subject><subject>Alprostadil - metabolism</subject><subject>Alprostadil - pharmacology</subject><subject>Animals</subject><subject>Biotransformation</subject><subject>Blood Proteins - metabolism</subject><subject>Cimetidine - pharmacology</subject><subject>Dogs</subject><subject>Erythrocytes - metabolism</subject><subject>Female</subject><subject>Half-Life</subject><subject>Haplorhini</subject><subject>Humans</subject><subject>Intestinal Absorption</subject><subject>Kinetics</subject><subject>Liver - drug effects</subject><subject>Liver - enzymology</subject><subject>Male</subject><subject>Mice</subject><subject>Misoprostol</subject><subject>Mixed Function Oxygenases - metabolism</subject><subject>Protein Binding</subject><subject>Ranitidine - pharmacology</subject><subject>Rats</subject><subject>Tissue Distribution</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDFPwzAQhS0EKqWwsCNlYkAKnO3YZ49QUUAqYoE5sp2LCCR1iZOBf09QC9Pd8Om9p4-xcw7XHABvfA1cgpUWD9icK5S5UNocsjlwPf2c62N2ktIHAFjkesZm0koBhZwz9UyD87FtUpe5TZVt313fuRA_mw0NTcjSMFYNpSzWWdekuO1jGmJ7yo5q1yY6298Fe1vdvy4f8_XLw9Pydp0HiTjkKmBhUKEzyK0g7etaY_BIximrDQbtnQMHNuhgkQppfKEAjBW8ssGSXLDLXe7U-zVSGsppRKC2dRuKYypRF0IJUUzg1Q4M08DUU11u-6Zz_XfJofx1VN6t_hxN8MU-dfQdVf_oXor8AbTkYH0</recordid><startdate>198511</startdate><enddate>198511</enddate><creator>Schoenhard, G</creator><creator>Oppermann, J</creator><creator>Kohn, F E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198511</creationdate><title>Metabolism and pharmacokinetic studies of misoprostol</title><author>Schoenhard, G ; Oppermann, J ; Kohn, F E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-5c748757a87192e6bff67cb7e8a59687c6baa0a09c6c97e438b45008921d9c9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Alprostadil - analogs & derivatives</topic><topic>Alprostadil - metabolism</topic><topic>Alprostadil - pharmacology</topic><topic>Animals</topic><topic>Biotransformation</topic><topic>Blood Proteins - metabolism</topic><topic>Cimetidine - pharmacology</topic><topic>Dogs</topic><topic>Erythrocytes - metabolism</topic><topic>Female</topic><topic>Half-Life</topic><topic>Haplorhini</topic><topic>Humans</topic><topic>Intestinal Absorption</topic><topic>Kinetics</topic><topic>Liver - drug effects</topic><topic>Liver - enzymology</topic><topic>Male</topic><topic>Mice</topic><topic>Misoprostol</topic><topic>Mixed Function Oxygenases - metabolism</topic><topic>Protein Binding</topic><topic>Ranitidine - pharmacology</topic><topic>Rats</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schoenhard, G</creatorcontrib><creatorcontrib>Oppermann, J</creatorcontrib><creatorcontrib>Kohn, F E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schoenhard, G</au><au>Oppermann, J</au><au>Kohn, F E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolism and pharmacokinetic studies of misoprostol</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>1985-11</date><risdate>1985</risdate><volume>30</volume><issue>11 Suppl</issue><spage>126S</spage><epage>128S</epage><pages>126S-128S</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><abstract>Absorption, metabolism and excretion of radiolabelled misoprostol were studied in laboratory animals and in humans. Dog and man were similar in terms of key parameters examined. Misoprostol itself was not present in plasma after its oral administration to humans. Misoprostol was rapidly converted by de-esterification to its free acid. This metabolite possesses significant desired pharmacological activity. Further metabolic conversion occurs over time via beta-oxidation of the alpha side chain, omega-oxidation of the beta side chain and reduction to the prostaglandin F analogs. The serum protein binding of the free acid metabolite of misoprostol was similar in young (81-88%) and elderly (81-89%) people. Binding was concentration-independent and was not altered by drugs which one would expect to be co-administered with misoprostol. In the rat, misoprostol neither inhibited nor induced drug metabolizing enzymes. A radio-immunological assay for measurement of the free acid metabolite in human plasma has been developed. This method has a sensitivity of 23 pg/ml and appears to be sufficiently sensitive for use in clinical trials.</abstract><cop>United States</cop><pmid>3932043</pmid><doi>10.1007/bf01309397</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0163-2116 |
| ispartof | Digestive diseases and sciences, 1985-11, Vol.30 (11 Suppl), p.126S-128S |
| issn | 0163-2116 1573-2568 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76425224 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Alprostadil - analogs & derivatives Alprostadil - metabolism Alprostadil - pharmacology Animals Biotransformation Blood Proteins - metabolism Cimetidine - pharmacology Dogs Erythrocytes - metabolism Female Half-Life Haplorhini Humans Intestinal Absorption Kinetics Liver - drug effects Liver - enzymology Male Mice Misoprostol Mixed Function Oxygenases - metabolism Protein Binding Ranitidine - pharmacology Rats Tissue Distribution |
| title | Metabolism and pharmacokinetic studies of misoprostol |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T18%3A12%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolism%20and%20pharmacokinetic%20studies%20of%20misoprostol&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Schoenhard,%20G&rft.date=1985-11&rft.volume=30&rft.issue=11%20Suppl&rft.spage=126S&rft.epage=128S&rft.pages=126S-128S&rft.issn=0163-2116&rft.eissn=1573-2568&rft_id=info:doi/10.1007/bf01309397&rft_dat=%3Cproquest_cross%3E76425224%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76425224&rft_id=info:pmid/3932043&rfr_iscdi=true |